About this Class

The CCR Genomics, Sequencing and Single Cell Analysis Core Facilities are pleased to host a virtual technology seminar with Illumina. Presentation overview: For decades cancer methylation studies have provided insights into tumorigenic pathways and cancer progression. Now new solutions such as cell-free DNA methylation sequencing  for ultrasensitive and non-invasive cancer detection and classification, and DNA methylation at single-cell resolution have emerged to meet the field's rapidly evolving needs. Additionally, methylation arrays minimize cost per sample and enable high-throughput quantitative interrogation of methylation sites across the genome. In this seminar, we will review recent research that incorporates the latest DNA methylation approaches and introduce valuable tools that add another dimension to the study of cancer. About the Speaker:  Mike Gregory has supported genomics initiatives at the NIH for over 15 years. Gregory is currently the Sr. Sequencing Specialist at Illumina and supports all local federal government accounts. Prior to joining Illumina, Gregory was the Sequencing Production Group Leader at the NIH’s Intramural Sequencing Center (NISC) at the NHGRI. Gregory holds a bachelor’s degree in biotechnology from James Madison University, and a master’s degree in biotechnology from Johns Hopkins University with a focus on assay development.   For questions about this seminar, please contact: Liz Conner, Ph.D. CCR Genomics Core Webinar number:2317 518 2763 Webinar password: Please obtain your webinar password from your host.